Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hanny Al-Samkari

Showing results (81-90 of 201) with videos related to

Pageof 21
Sort By:
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 6, 2022
Pembrolizumab-Induced Acquired Amegakaryocytic Thrombocytopenia and Successful Combination Treatment With Eltrombopag, Romiplostim and Cyclosporine: A Brief CommunicationAlbert K Park, Jong C Park, Hanny Al-Samkari
British Journal of Haematology|February 6, 2024
The problem of immune thrombocytopenia refractory to both eltrombopag and romiplostimHanny Al-Samkari, Alexandra Schifferli, Tomas J Gonzalez-Lopez
Journal of Thrombosis and Haemostasis : JTH|July 10, 2026
Direct Glycoprotein-Specific Platelet Autoantibodies Detected in a Majority of Patients with Persistent Chemotherapy-Induced ThrombocytopeniaAndrew B Song, Brian R Curtis, Hanny Al-Samkari
The Lancet. Haematology|May 2, 2022
The case for classical haematology: the impact of a name and the future of a fieldHanny Al-Samkari, Alison W Loren, Alfred I Lee
Research and Practice in Thrombosis and Haemostasis|December 14, 2020
A hematologic support score for longitudinal measurement of blood and iron requirements in hereditary hemorrhagic telangiectasia and other chronic bleeding disordersHanny Al-Samkari, Rakhi P Naik, Neil A Zakai
Research and Practice in Thrombosis and Haemostasis|July 21, 2020
Serum complement levels in immune thrombocytopenia: Characterization and relation to clinical featuresAbraham Z Cheloff, David J Kuter, Hanny Al-Samkari
Therapeutic Advances in Hematology|June 12, 2020
The role of romiplostim for pediatric patients with immune thrombocytopeniaHanny Al-Samkari, Rachael F Grace, David J Kuter
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 18, 2024
Alessandro Casini, Hanny Al-Samkari, Catherine Hayward, et al.
Journal of Thrombosis and Thrombolysis|June 20, 2023
Antithrombotic therapy for atrial fibrillation in hereditary hemorrhagic telangiectasiaZain M Virk, T Lee Richardson, Hanny Al-Samkari
Expert Opinion on Pharmacotherapy|October 23, 2020
An evaluation of avatrombopag for the treatment of thrombocytopeniaZain Mohammad Virk, David J Kuter, Hanny Al-Samkari
Pageof 21

Showing results (81-90 of 201) with videos related to

Sort By:
Pageof 21
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 6, 2022
Pembrolizumab-Induced Acquired Amegakaryocytic Thrombocytopenia and Successful Combination Treatment With Eltrombopag, Romiplostim and Cyclosporine: A Brief CommunicationAlbert K Park, Jong C Park, Hanny Al-Samkari
British Journal of Haematology|February 6, 2024
The problem of immune thrombocytopenia refractory to both eltrombopag and romiplostimHanny Al-Samkari, Alexandra Schifferli, Tomas J Gonzalez-Lopez
Journal of Thrombosis and Haemostasis : JTH|July 10, 2026
Direct Glycoprotein-Specific Platelet Autoantibodies Detected in a Majority of Patients with Persistent Chemotherapy-Induced ThrombocytopeniaAndrew B Song, Brian R Curtis, Hanny Al-Samkari
The Lancet. Haematology|May 2, 2022
The case for classical haematology: the impact of a name and the future of a fieldHanny Al-Samkari, Alison W Loren, Alfred I Lee
Research and Practice in Thrombosis and Haemostasis|December 14, 2020
A hematologic support score for longitudinal measurement of blood and iron requirements in hereditary hemorrhagic telangiectasia and other chronic bleeding disordersHanny Al-Samkari, Rakhi P Naik, Neil A Zakai
Research and Practice in Thrombosis and Haemostasis|July 21, 2020
Serum complement levels in immune thrombocytopenia: Characterization and relation to clinical featuresAbraham Z Cheloff, David J Kuter, Hanny Al-Samkari
Therapeutic Advances in Hematology|June 12, 2020
The role of romiplostim for pediatric patients with immune thrombocytopeniaHanny Al-Samkari, Rachael F Grace, David J Kuter
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 18, 2024
Alessandro Casini, Hanny Al-Samkari, Catherine Hayward, et al.
Journal of Thrombosis and Thrombolysis|June 20, 2023
Antithrombotic therapy for atrial fibrillation in hereditary hemorrhagic telangiectasiaZain M Virk, T Lee Richardson, Hanny Al-Samkari
Expert Opinion on Pharmacotherapy|October 23, 2020
An evaluation of avatrombopag for the treatment of thrombocytopeniaZain Mohammad Virk, David J Kuter, Hanny Al-Samkari
Pageof 21